MINNEAPOLIS--(BUSINESS WIRE)--Expanding the application of endovascular aortic repair around the world, Medtronic, Inc. (NYSE: MDT), today announced two major milestones: the international market launch of the Endurant Abdominal Stent Graft System and the first implants of this next-generation medical device in the U.S. clinical trial.
